maziar mike doustdar - Search News

News

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

The Wall Street Journal on MSN · 7h

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors

Medical Dialogues · 8h

Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle

Delhi: Global healthcare major Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new President and Chief Executive Officer, effective 7 August 2025. The move comes as part

2don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

2don MSN

Novo's new CEO faces sceptical investors with Wegovy US sales in focus

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...

The Copenhagen Post1d

An international is the new CEO of Danish largest company: “I have embraced the Danish spirit, but we know no borders”

It’s not unusual for a non-national to be CEO, executive director, or president of a company in a country. “C-level” positions and top management roles are often international. However, when the ...

Devdiscourse1d

Pharma Industry Shaken: New Leadership and Tariff Challenges

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results